This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| Smiths Group PLC | 1,766.5 | 2.3% |
| Ocado Group PLC | 3,466.0 | 2.2% |
| Smurfit Kappa Group PLC | 959.5 | 2.1% |
| Rs Group PLC | 847.2 | 2.1% |
| Segro PLC | 658.8 | 2.0% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| Anglo American PLC | 3,360.0 | -3.1% |
| Astrazeneca PLC | 10,288.9 | -2.8% |
| Fresnillo PLC | 801.8 | -2.4% |
| Vodafone Group PLC | 91.1 | -2.2% |
| Rio Tinto PLC | 6,190.0 | -2.0% |
| Major World Indices | Price | % Chg | 1 YEAR |
| UK 100 INDEX | 7,749 | -0.3% | 3.3% |
| DOW JONES INDUS. AVG | 33,826 | -0.8% | -4.5% |
| DAX INDEX | 15,159 | 0.2% | -2.7% |
| NIKKEI 225 | 27,347 | 0.1% | 1.0% |
| S&P/ASX 200 INDEX | 7,502 | 0.3% | 5.8% |
| Commodities | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 78.09 | -0.99% |
| Brent Crude (ICE) | USD/bbl. | 84.35 | -1.30% |
| Gold Spot | USD/t oz. | 1,929 | 0.1% |
| Copper (Comex) | USd/lb. | 415 | -1.9% |
Click graph to enlarge
The UK 100 called to open +34 points at 7795. The UK 100 looks set to make a strong start to the day as the Federal Reserve slowed the pace of interest rate increases and the Fed chairman, Jerome Powell, stated "the disinflationary process has started.” On Wall Street US markets took heart from the slower pace of rate rises and the Dow which had been down over 300 points earlier in the session, closed in positive territory, up 7 points, the Nasdaq Composite added 232 points, 2%, to close at 11,816, while the S&P improved by 43 points or 1.1%, to trade at 4,119. Focus will now switch to interest rates decisions today from the Bank of England and the European Central Bank.
Anglo American report that their 2022 copper production has grown 3% to 664 kt from 647 kt YoY. They say outlook for 2023 remains very dry in Chile.
BT Group has stuck to its FY outlook despite the pressure of high energy costs and other inflationary headwinds, as they reported a 3% dip in Q3 adjusted revenue, just below market expectations.
Cranswick says all four product categories were strongly ahead of Q3 YoY as December trading was robust due to strong customer demand. They expect current financial year outlook to remain in line with expectations.
GlaxoSmithKline state that Jesduvroq/daprodustat has been approved by the US FDA for anaemia of chronic kidney disease.
Renishaw reports that their H1 pretax profit has declined 5% YoY to £77.8m from £81.5m. They expect their FY adjusted pretax profit to be between £140-165m.
Shell posted record Q4 profit of $9.8bn on the back of a strong recovery in earnings from its Liquefied Natural Gas trading, beating analyst forecasts. They reported 2022 annual earnings of $39.9bn, doubling from a year earlier and far exceeding the previous record of $31bn in 2008. They have announced a $4bn share buyback, to be completed by Q1 results announcement.
Wizz Air carries 4.1m passengers in January, up 73% YoY from 2.4m. January capacity up 60% YoY to 4.8m seats from 3m seats.
Goldman Sachs Downgrades Standard Chartered to Neutral from Buy (8 Buys / 9 Holds / 0 Sells)
Airtel Africa
BT Group
Cranswick
Renishaw
Shell
US
Eli Lilly and Co
Merck & Co
Alphabet Inc
Amazon.com
Apple Inc
Ford Motor Co
Qualcomm Inc
Starbucks Corp
UK
None
US
Aon
German Trade Balance s.a
Bank of England Minutes
Bank of England Monetary Policy Report
BoE Interest Rate Decision
BoE Monetary Policy Summary
BoE's Governor Bailey speech
ECB Monetary Policy Decision Statement
ECB Rate On Deposit Facility
US Initial Jobless Claims
ECB Press Conference
US Factory Orders
UK 100 companies going ex-dividend on 2nd February 2023:
None
UK 250 companies going ex-dividend on 2nd February 2023:
Paragon Banking Group
Merchants Trust
JLEN Environmental Assets Group
Bluefield Solar Income Fund
Edinburgh Investment Trust
IG Group Holdings
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.